- Corporate Officers - A
- Arkowitz David
Insider Trading History of Arkowitz David
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Arkowitz David since 2017.
This trader's CIK number is 1296999.
At the time of last reporting, Arkowitz David was the Officer of Kineta, Inc./de. (stock ticker symbol KANT).
Also see all insider trading activities at Kineta, Inc./de.
Note that in the past
Arkowitz David also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Ibio, Inc. (IBIO) by Arkowitz David
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2025 | IBIO | 18,382 | $49,999 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Flexion Therapeutics Inc (FLXN) by Arkowitz David
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2021 | FLXN | 0 | $0 | 8,302 | $83,707 | 0 | $0 |
| 2020 | FLXN | 0 | $0 | 5,508 | $26,253 | 0 | $0 |
| 2019 | FLXN | 6,500 | $75,587 | 2,248 | $22,614 | 0 | $0 |
| 2018 | FLXN | 8,000 | $159,900 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Seres Therapeutics, Inc. (MCRB) by Arkowitz David
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2024 | MCRB | 0 | $0 | 3,939 | $4,254 | 10,625 | $0 |
| 2023 | MCRB | 0 | $0 | 4,066 | $5,489 | 13,209 | $0 |
Yearly summary of insider trading at Kineta, Inc./de (KANT) by Arkowitz David
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2025 | KANT | 0 | $0 | 0 | $0 | 12,500 | $7,637 |
Yearly summary of insider trading at F-star Therapeutics, Inc. (SBPH) by Arkowitz David
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2017 | SBPH | 2,500 | $30,612 | 0 | $0 | 0 | $0 |
Insider trading activities at 5 companies by Arkowitz David:
1. Ibio, Inc. (IBIO)
2. Flexion Therapeutics Inc (FLXN)
3. Seres Therapeutics, Inc. (MCRB)
4. Kineta, Inc./de (KANT)
5. F-star Therapeutics, Inc. (SBPH)
Table 1. Insider trading of Ibio, Inc. (IBIO) by Arkowitz David
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2025-01-10 | IBIO | Buy | 18,382 | 2.72 | 49,999 |
Table 2. Insider trading of Flexion Therapeutics Inc (FLXN) by Arkowitz David
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2021-05-10 | FLXN | Sale | 2,229 | 7.23 | 16,115 |
| 2021-01-05 | FLXN | Sale | 6,073 | 11.13 | 67,592 |
| 2020-05-07 | FLXN | Sale | 2,413 | 10.88 | 26,253 |
| 2020-01-03 | FLXN | Sale | 3,095 | .00 | 0 |
| 2019-05-31 | FLXN | Buy | 2,500 | 11.05 | 27,627 |
| 2019-05-13 | FLXN | Buy | 4,000 | 11.99 | 47,960 |
| 2019-05-08 | FLXN | Sale | 2,248 | 10.06 | 22,614 |
| 2018-11-09 | FLXN | Buy | 4,000 | 16.55 | 66,220 |
| 2018-08-09 | FLXN | Buy | 4,000 | 23.42 | 93,680 |
Table 3. Insider trading of Seres Therapeutics, Inc. (MCRB) by Arkowitz David
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2024-02-15 | MCRB | Option Ex | 10,625 | .00 | 0 |
| 2024-02-16 | MCRB | Sale | 3,939 | 1.08 | 4,254 |
| 2023-10-27 | MCRB | Option Ex | 13,209 | .00 | 0 |
| 2023-10-30 | MCRB | Sale | 4,066 | 1.35 | 5,489 |
Table 4. Insider trading of Kineta, Inc./de (KANT) by Arkowitz David
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2025-06-23 | KANT | Option Ex | 12,500 | .61 | 7,637 |
Table 5. Insider trading of F-star Therapeutics, Inc. (SBPH) by Arkowitz David
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2017-08-04 | SBPH | Buy | 2,500 | 12.24 | 30,612 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Arkowitz David
(Officer of Kineta, Inc./de at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.